From the report for H1 :
http://www.empired.com/Global/Case studies/Half Yearly Financial Report 2016.pdf
Revenue for the business for the half-year was $78.5 million (HY2014: $50.5 million) representing an increase of 56% on the same period in the preceding half-year.
Consolidated comprehensive loss after tax for the half-year was $3,702,662 (HY2014: comprehensive income of $1,151,447).
So - they had 56% more revenue - but made a loss of $3.7m for the half - compared to $1.1m profit the previous. And no dividend.
And - they pushed out the payment for Intergen to July 1, to get it OUT of this FY.
I'm expecting another loss. And another drop. I might re-buy when it drops under 20c.
- Forums
- ASX - By Stock
- EPD
- Ann: Cohesion Market Update-EPD.AX
Ann: Cohesion Market Update-EPD.AX, page-18
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online